Teenagers are taking a cancer drug to get taller, doctors warn
Teenagers are taking a cancer drug to get taller, doctors warn
Teenagers are taking a cancer drug to get taller, doctors warn
Key points
اہم نکات
मुख्य बातें
- Teenagers are taking erdafitinib, a prescription drug used to treat advanced bladder cancer, in the hope of growing taller, doctors have warned.
- The trend, known online as heightmaxxing, has spread on social media, where young men share tips for improving their appearance.
- The drug, sold as Balversa, can cause serious side effects including joint pain, nosebleeds and nail infections, and doctors say its long-term effects on children are unknown.
- Teenagers are taking erdafitinib, a prescription drug used to treat advanced bladder cancer, in the hope of growing taller, doctors have warned.
- The trend, known online as heightmaxxing, has spread on social media, where young men share tips for improving their appearance.
- The drug, sold as Balversa, can cause serious side effects including joint pain, nosebleeds and nail infections, and doctors say its long-term effects on children are unknown.
- Teenagers are taking erdafitinib, a prescription drug used to treat advanced bladder cancer, in the hope of growing taller, doctors have warned.
- The trend, known online as heightmaxxing, has spread on social media, where young men share tips for improving their appearance.
- The drug, sold as Balversa, can cause serious side effects including joint pain, nosebleeds and nail infections, and doctors say its long-term effects on children are unknown.
Teenagers are taking erdafitinib, a prescription drug used to treat advanced bladder cancer, in the hope of growing taller, doctors have warned. The trend, known online as heightmaxxing, has spread on social media, where young men share tips for improving their appearance. The drug, sold as Balversa, can cause serious side effects including joint pain, nosebleeds and nail infections, and doctors say its long-term effects on children are unknown. One 17-year-old from New York said he had taken the drug on and off since he was 15 and had suffered joint pain and frequent nosebleeds. Medical experts strongly warn against using the drug without approval, saying there is no safe way to increase height once the growth plates in the bones have closed.
Teenagers are taking erdafitinib, a prescription drug used to treat advanced bladder cancer, in the hope of growing taller, doctors have warned. The trend, known online as heightmaxxing, has spread on social media, where young men share tips for improving their appearance. The drug, sold as Balversa, can cause serious side effects including joint pain, nosebleeds and nail infections, and doctors say its long-term effects on children are unknown. One 17-year-old from New York said he had taken the drug on and off since he was 15 and had suffered joint pain and frequent nosebleeds. Medical experts strongly warn against using the drug without approval, saying there is no safe way to increase height once the growth plates in the bones have closed.
Teenagers are taking erdafitinib, a prescription drug used to treat advanced bladder cancer, in the hope of growing taller, doctors have warned. The trend, known online as heightmaxxing, has spread on social media, where young men share tips for improving their appearance. The drug, sold as Balversa, can cause serious side effects including joint pain, nosebleeds and nail infections, and doctors say its long-term effects on children are unknown. One 17-year-old from New York said he had taken the drug on and off since he was 15 and had suffered joint pain and frequent nosebleeds. Medical experts strongly warn against using the drug without approval, saying there is no safe way to increase height once the growth plates in the bones have closed.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।